Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
Efficacy of Spectacle Correction Using Defocus Incorporated Multiple Segments in the Myopic Population
Marketa Zakova1, Martin Fus1, Leos Tejkl1
1Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic.
Aim:
The objective of this study was to evaluate the efficacy of DIMS (Defocus Incorporated Multiple Segments) in comparison to control group (CTRL) in a wide age group of European progressive myopes (6-26 years).
Methods:
In this prospective, non-randomised observational study, 78 myopes with progression myopia to -0.25 to -8.5 D and astigmatism to -0.25 to -2.25 D chose DIMS (n=54) or single vision lenses (SV) (n=24). Baseline measurements included spherical equivalent refraction (SER) and axial length (AL), evaluated at regular intervals.
Results:
In participants younger than 15 years of age, slower progression of myopia (SER) (SER -0.25±0.35 D) and reduced axial elongation (0.09 ± 0.16 mm) was observed in Group 1 (DIMS) compared to Group 2 (CTRL) (SER -0.73 ± 0.57 D, AL 0.30 ± 0.20 mm), both significantly at p-value <0.05. In participants over 15 years of age, Group 3 (DIMS) exhibited minimal myopia progression (SER -0.24 ± 0.29D) and negligible axial elongation (0.00 ± 0.07 mm), Group 4 (CTRL) demonstrated more pronounced axial elongation (SER -0.20 ± 0.53D, AL 0.01 ± 0.06 mm).
Conclusion:
It can be stated that the DIMS variant is 68.7% more effective in the category of subjects younger than 15 years of age in the effect on AL and 65.6% more effective in the effect on SER compared to the SV lenses. This deceleration in myopia progression is statistically significant in the under 15 age group. A statistically significant difference in the effect on SER in this age group was observed for DIMS.
Related Concept Videos
Focusing of Light in the Eye
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

